Abiopharma

Valvoline Inc. Named One of America’s Most Trustworthy Companies by Newsweek

eToros AI investing companion Tori gets real-time X intelligence, powered by Grok 4.2

Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences

Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026

Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026

ManpowerGroup Reports 1st Quarter 2026 Results

Snap-on Incorporated to Webcast 2026 Annual Shareholder Meeting

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

Client Growth & Engagement Drive Record Schwab 1Q Results

PHARMING GROUP NV (PHAR) Files Form 6-K

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-04-16 <b>AccNo:</b> 0001839882-26-020292 <b>Size:</b> 543 KB

Annual General Meeting :

Extraordinary/ Special General Meeting:

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change of Interest of Director - Ow Yong Thian Soo

General Announcement: CORRIGENDUM TO THE NOTICE OF EGM TO BE HELD ON 30 APRIL 2026